Results 1 to 10 of about 238,844 (257)

Impact of adjuvant chemotherapy delay on overall survival in early-stage breast cancer: a retrospective analysis [PDF]

open access: yesFrontiers in Oncology
BackgroundIn Early-Stage Breast Cancer (EBC), there is no clear consensus on the ideal window for initiation of adjuvant chemotherapy from the time of definitive surgery.
Ahmad Alhalabi   +5 more
doaj   +2 more sources

Chemotherapy adjuvant and chemotherapy-induced neutropenia

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2022
Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj   +3 more sources

Adjuvant Chemotherapy [PDF]

open access: yesThoracic Surgery Clinics, 2020
Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
  +5 more sources

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2022
Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi   +12 more
doaj   +1 more source

Adjuvant Chemotherapy [PDF]

open access: yesSurgical Clinics of North America, 1986
At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
C K, Osborne, C A, Coltman
openaire   +4 more sources

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer

open access: yesAnnals of Gastroenterological Surgery, 2023
Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi   +8 more
doaj   +1 more source

Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly.
Ying Jin   +10 more
doaj   +1 more source

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer

open access: yesScientific Reports, 2022
Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival
Mu-Hung Tsai   +5 more
doaj   +1 more source

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

open access: yesFrontiers in Oncology, 2022
BackgroundFor rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy.
Yu-Hsuan Kuo   +12 more
doaj   +1 more source

Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients

open access: yesCancer Medicine, 2023
Background The survival of hemodialysis (HD) patients with cancer is poor, which may be caused by undertreatment due to renal dysfunction. Particularly, adjuvant chemotherapy after surgery may be considered optional because of its preventive nature. This
Taisuke Ishii   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy